In a report published Friday, Oppenheimer analyst Steven Lichtman reiterated an Outperform rating on Insulet Corporation (NASDAQ: PODD), but lowered the price target from $50.00 to $39.00.
In the report, Oppenheimer noted, “Comments by PODD...
NEW YORK (TheStreet) -- Shares of Insulet Corp.
fell to a 52-week low of $27.02 today before recovering to $30.63 after JPMorgan downgraded the company to "neutral" from "overweight," and cut its price target to $35 from $45 following...
Duane DeSisto Retires From the Company After 13 YearsBILLERICA, MA -- (Marketwired) -- 09/16/14 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced...
Seasoned Senior Medical Device Executive to Join Insulet BoardBEDFORD, MA -- (Marketwired) -- 08/15/14 -- Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today...
Insulet Corp. (NASDAQ:PODD)
Q2 2014 Earnings Conference Call
August 7, 2014 5:00 PM ET
Duane M. DeSisto – President and Chief Executive Officer
Brian K. Roberts – Chief Financial Officer
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to Insulet (PODD):
Insulet (PODD) is competing against Mini Med, a division of Medtronic, for the insulin delivery system segment. The product has a needle which is inserted until an audible sound is heard, then the needle withdraws leaving behind a tethlon tube. Insuline is dripped from the pod into the body via the tube. When the pod is low on the solution, more is added. This avoids the nasty needle sticks many diabetics loath.
The pod can be worn many places on the body and has no major tubes of complicated computer readouts, vs. the typical insulin pump.
Often a physician asks the patient to try wearing the pod while it drips saline. Uptake is high afterwards as the pod is so comfortable.
Per the CEO, Duane Desisto, they may have a pump company burried in a pod company. Meaning that other drugs may be delivered via the pod.